iPierian Appoints Dr. Matthew Plunkett as CFO
iPierian, a San Francisco-based biopharmaceutical company, has appointed Matthew Plunkett, PhD, as vice president and chief financial officer (CFO).
Previously, Plunkett spent nine years at Oppenheimer & Co, most recently as managing director where he lead the firm’s biotechnology investment banking practice for the West Coast. His investment banking experience includes over 60 completed biopharmaceutical transactions, including initial public offerings (IPOs), follow-on offerings, convertible debt, private placements, merger and acquisition (M&A) and financial advisory assignments. Prior to this, he worked as a research scientist at Sunesis Pharmaceuticals and at Axys Advanced Technologies.
Plunkett received a PhD in Organic Chemistry from the University of California, Berkeley.